KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
Massive opportunities for growth are opening up in China for foreign producers of medical devices thanks in part to the negligible competitive threat being posed by the domestic manufacturers.
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.
Sector Studies - These studies feature the industry insights and latest developments of specific sectors in China.